Search

Search Constraints

You searched for: Author/Creator Lee, Hans C.

Search Results

1. A phase I/II trial of the combination of lenalidomide, thalidomide and dexamethasone in relapsed and/or refractory multiple myeloma. Issue 12 (4th October 2019)

2. A phase one trial of carfilzomib, bendamustine, and dexamethasone in relapsed and/or refractory multiple myeloma. Issue 7 (6th May 2021)

4. Association between race and treatment patterns and survival outcomes in multiple myeloma: A Connect MM Registry analysis. Issue 19 (24th July 2020)

5. Black multiple myeloma patients undergoing upfront autologous stem cell transplant have similar survival outcomes compared to Whites: A propensity‐score matched analysis. Issue 12 (4th October 2021)

6. Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi‐institutional experience. Issue 7 (2nd May 2022)

8. Effect of initial treatment on health‐related quality of life in patients with newly diagnosed multiple myeloma without immediate stem cell transplant intent: results from the Connect® MM Registry. (29th October 2020)

9. Health‐related quality of life in patients with light chain amyloidosis treated with bortezomib, cyclophosphamide, and dexamethasone ± daratumumab: Results from the ANDROMEDA study. Issue 6 (30th March 2022)

10. Longer term outcomes with single‐agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13‐month follow‐up from the pivotal DREAMM‐2 study. Issue 22 (27th July 2021)